可溶性fms样酪氨酸激酶-1升高与COVID-19孕妇不良结局相关
这项前瞻性队列研究纳入113例住院COVID-19孕妇,发现sFlt-1 MoM升高与重症肺炎、ICU入住、病毒性脓毒症及孕产妇死亡风险增加相关,且在10%假阳性率下对上述结局有一定检出率。PlGF在重症与非重症肺炎间无差异。
要点
- sFlt-1 MoM升高提示COVID-19孕妇不良结局风险增加。
- sFlt-1对重症肺炎、ICU入住、病毒性脓毒症和死亡有预测价值。
- PlGF在重症与非重症COVID-19肺炎孕妇间无差异。
局限性
- 单中心研究,样本量113例。
- 部分结局事件数较少,仅对超过5例的结局校正 gestational age。
- 孕产妇死亡仅报告未校正OR。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: In addition to the lungs, the placenta and the endothelium can be affected by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Soluble fms-like tyrosine kinase-1 (sFlt-1) and placental growth factor (PlGF) are markers of endothelial dysfunction and could potentially serve as predictors of severe coronavirus disease 2019 (COVID-19). We aimed to investigate the association of serum concentrations of sFlt-1 and PlGF with the severity of COVID-19 in pregnancy.
METHODS: This was a prospective cohort study carried out in a tertiary care hospital in Mexico City, Mexico. Symptomatic pregnant women with a positive reverse-transcription quantitative polymerase chain reaction test for SARS-CoV-2 infection who fulfilled the criteria for hospitalization were included. The primary outcome was severe pneumonia due to COVID-19. Secondary outcomes were intensive care unit (ICU) admission, viral sepsis and maternal death. sFlt-1 levels were expressed as multiples of the median (MoM). The association between sFlt-1 and each adverse outcome was explored by logistic regression analysis, adjusted for gestational age for outcomes occurring in more than five patients, and the predictive performance was assessed by receiver-operating-characteristics-curve analysis.
RESULTS: Among 113 pregnant women with COVID-19, higher sFlt-1 MoM was associated with an increased probability of severe pneumonia (adjusted odds ratio (aOR), 1.817 (95% CI, 1.365-2.418)), ICU admission (aOR, 2.195 (95% CI, 1.582-3.047)), viral sepsis (aOR, 2.318 (95% CI, 1.407-3.820)) and maternal death (unadjusted OR, 5.504 (95% CI, 1.079-28.076)). At a 10% false-positive rate, sFlt-1 MoM had detection rates of 45.2%, 66.7%, 83.3% and 100% for severe COVID-19 pneumonia, ICU admission, viral sepsis and maternal death, respectively. PlGF values were similar between women with severe and those with non-severe COVID-19 pneumonia.
CONCLUSION: sFlt-1 MoM is higher in pregnant women with severe COVID-19 and has the capability to predict serious adverse pregnancy events, such as severe pneumonia, ICU admission, viral sepsis and maternal death. © 2021 International Society of Ultrasound in Obstetrics and Gynecology.
引用
- Torres-Torres J, Espino-Y-Sosa S, Poon LC, et al. Increased levels of soluble fms-like tyrosine kinase-1 are associated with adverse outcome in pregnant women with COVID-19. Ultrasound Obstet Gynecol. 2021. PMID: 34664753. doi:10.1002/uog.24798
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。